subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_code: "520"
part_subject: "ORAL DOSAGE FORM NEW ANIMAL DRUGS"
subpart_code: "B"
subpart_subject: "Specific Administrative Rulings and Decisions"
section_number: "520.970"
section_subject: "Flunixin."
cfr_reference: "21 CFR 520.970"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 500 to 599"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
(a)Specifications. (1) Each 10-gram (g) packet of granules contains flunixin meglumine equivalent to 250 milligrams (mg) of flunixin.
(2)Each 30-g syringe of paste contains flunixin meglumine equivalent to 1,500 mg of flunixin.
(b)Sponsors. See sponsors in § 510.600(c) of this chapter for use as in paragraph (c) of this section.
(1)No. 000061 for use of products described in paragraph (a).
(2)No. 061133 for use of the product described in paragraph (a)(2).
(c)Conditions of use in horses—(1) Amount. 0.5 mg per pound of body weight per day for up to 5 days.
(2)Indications for use. For alleviation of inflammation and pain associated with musculoskeletal disorders.
(3)Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.